Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials
Tullio Palmerini(University of Bologna), Gregg W. Stone(Cardiovascular Institute of the South), Philippe Généreux(Morristown Medical Center), Yangsoo Jang(Yonsei University), Deepak L. Bhatt(Mount Sinai Hospital), Claudio Rapezzi(University of Ferrara), Umberto Benedetto(University of Oxford), Alexandre Abizaid(Universidade de São Paulo), Stefano De Servi(University of Pavia), Hyo‐Soo Kim(Inje University Ilsan Paik Hospital), Myeong‐Ki Hong(Yonsei University), Mario Petrou(University of Oxford), Giuseppe Biondi‐Zoccai(Maria Cecilia Hospital), Diego Della Riva(University of Bologna), Fausto Feres(Instituto Dante Pazzanese de Cardiologia), Kyung Woo Park(Seoul National University Hospital), Carlotta Orlandi(University of Bologna), Byeong‐Keuk Kim(Yonsei University)
Cited by 394
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k